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An atypical interaction explains the high-affinity
of a non-hydrolyzable S-linked 1,6-a-mannanase
inhibitor†
Tyson Belz,a Yi Jin,b Joan Coines,c Carme Rovira, *cd Gideon J. Davies *b and
Spencer J. Williams *a
The non-hydrolyzable S-linked azasugars, 1,6-a-mannosylthio- and
1,6-a-mannobiosylthioisofagomine, were synthesized and shown
to bind with high affinity to a family 76 endo-1,6-a-mannanase from
Bacillus circulans. X-ray crystallography showed an atypical inter-
action of the isofagomine nitrogen with the catalytic acid/base.
Molecular dynamics simulations reveal that the atypical binding
results from sulfur perturbing the most stable form away from the
nucleophile interaction preferred for the O-linked congener.
1,6-a-Mannans are polysaccharides produced by fungi and bacteria.1,2
In the fungal glycocalyx, such as that of the ascomycetes
Saccharomyces cerevisiae and Candida albicans, they are present
as part of the outer chainmannan,1 and are especially abundant in
the latter organism, comprising up to 40% of the mass of the cell
wall.3 Within bacteria, 1,6-a-mannans are found within the lipo-
mannans and lipoarabinomannans of actinomycetes such as
mycobacteria and corynebacteria.4 1,6-a-Mannans are degraded
by endo-1,6-a-mannanases, enzymes that cleave the polysaccharide
chains into smaller fragments that are then further degraded by
exo-acting mannosidases. All known 1,6-a-mannanases fall into
family 76 of the glycoside hydrolase (GH) classification scheme
(www.cazy.org; www.cazypedia.org),5 which also includes putative
fungal transglycosidases that have been proposed to act on protein
glycosylphosphatidylinositol anchors.1,6 The gut microbiota
resident Bacteroides thetaiotaomicron produces GH76 endo-1,6-
a-mannanases as cell surface and periplasmic enzymes that
enable the depolymerisation of fungal cell wall mannan
consumed in the human diet.7 GH family 76 enzymes are also
deployed by the soil bacterium Bacillus circulans,8 possibly to
enable nutrient acquisition from fungal or actinomycete cell
wall fragments. We recently reported the first inhibitor of a GH
family 76 enzyme, ManIFG 1, which bound to the endo-1,6-a-
mannanase from B. circulans (BcGH76) with modest aﬃnity (KD
1.1 mM) (Fig. 1). This compound proved a useful mechanistic
probe, and supplied evidence supporting a boat conformation
at the enzyme-catalyzed transition state, and a OS2- B2,5-
1S5
conformation pathway for GH family 76 catalysis.9
The strategy used for the design of ManIFG 1 built upon a rich
history of glycosidase inhibitor design.10 It is widely appreciated
that exo-acting glycosidases are eﬀectively inhibited by sugar-
shaped heterocycle ‘warheads’ containing basic nitrogen in place
of C1 or O5, e.g. isofagomine (IFG) or deoxymannojirimycin
(DMJ). However, such simple monosaccharide-mimicking struc-
tures are frequently weak inhibitors of endo-acting glycosidases,
which have multiple substrate binding subsites. By adding sugar
residues to the warhead to mimic the natural substrate, eﬀective
inhibition of endoglycosidases can often be obtained. However, as
such compounds have glycosidic linkages within, and are by
virtue of the design process mimics of the substrate, the potential
exists that they may themselves be substrates for their target
enzymes. Typically, such concerns are limited for disaccharide-
based inhibitors, as disaccharides are rarely optimal substrates for
endoglycosidases, but become more significant for trisaccharides
and above. For example, cellotriose- and cellotetraose-like iso-
fagomines were shown to be cleaved by cellulase Cel9A from
Fig. 1 Structures of S-linked and O-linked isofagomine-based inhibitors
of Bacillus circulans endo-1,6-a-mannanase (BcGH76).
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Alicyclobacillus acidocaldarius.11 Additionally, the natural product
pseudo-tetrasaccharide inhibitor acarbose undergoes cleavage
(and transglycosidation) by amylases.12
The natural product chitinase inhibitor allosamidin, which
contains an allosamizoline inhibitor warhead, linked to N-acetyl-
b-allosamine residues, is a poor substrate for chitinases pre-
sumably by virtue of its mismatched sugar stereochemistry.13 An
alternative design strategy to limit hydrolysis by the target enzyme is
to attach sugar residues to the inhibitor warhead through non-
hydrolyzable linkages. For example, a C-glycosidic linkage was used
within a non-hydrolyzable epoxyalkyl C-glycoside inhibitor of an exo-
glycosidase,14 and alkylation of isofagomine on nitrogen by a sugar
residue provided a weak inhibitor of isoamylase.15 In a related vein,
a thioamide derivative of a chitooligosaccharide linked to the war-
head NAG-thiazoline was not a substrate for chitinases that utilize
neighboring group participation by virtue of the poorer nucleo-
philicity of the thionyl group relative to a carbonyl group.16 Given
the similarity in size and bonding geometry of sulfur and oxygen,
but the lower basicity of the former, an obvious alternative could be
to use sulfur in place of oxygen in an S-glycosidic linkage. S-Linked
oligosaccharides have been widely employed as non-hydrolyzable
mimics of glycosides, yet to our knowledge, no S-linked imino/
azasugar endoglycosidase inhibitors have been reported. Here
we report the synthesis and characterization of S-linked di- and
trisaccharide azasugar inhibitors ManSIFG 2 and (ManS)2IFG 3
targeting the endo-1,6-a-mannanase BcGH76.
We have previously reported the preparation of a family of
a-1,6-S-linked di-, tetra- and hexamannosides.17 The key element
of this approach was the use of a-mannosyl thioacetates or
isothiuronium bromides with defined anomeric stereochemistry
as precursors of thiolate nucleophiles that can be used for
substitution reactions of 6-deoxy-6-iodosugars. Accordingly, we
undertook the synthesis of the protected 6-iodo-isofagomine 5,
from isofagomine tartrate. The advanced intermediate, alcohol
4,9 was iodinated using the procedure of Garegg and Samuelsson
(I2, Ph3P, imidazole)
18 to aﬀord iodide 5 (Scheme 1a). Nucleo-
philic substitution proceeded in good yield upon treatment of 5
with mannosyl thiuronium bromide 619 in the presence of Et3N,
20
aﬀording disaccharide 7 (Scheme 1b). Deprotection was achieved in
two steps: Zemple´n deacylation using NaOMe inMeOH aﬀorded the
hexaol 8; then removal of the Cbz group using TFA/anisole, followed
by ion exchange chromatography, aﬀording ManSIFG 2. Similarly,
treatment of iodide 5 with disaccharide thioacetate 917 and Et2NH
21
aﬀorded the trisaccharide 10 (Scheme 1c). Deprotection was
achieved in a similar fashion aﬀording (ManS)2IFG 3.
The binding of ManSIFG 2 and (ManS)2IFG 3 to BcGH76 was
quantified by isothermal titration calorimetry. ManSIFG bound
with KD = 0.90 0.03 mM and (ManS)2IFG bound with KD = 24.7
7.9 nM. The aﬃnity of ManSIFG is similar to the O-linked variant,
ManIFG 1 (KD = 1.1 mM), showing that the eﬀect on aﬃnity upon
replacement of the glycosidic oxygen with sulfur is minimal.
(ManS)2IFG bound approximately 37-foldmore tightly thanManSIFG,
suggesting that extension of the inhibitor with an additional sugar
residue enables capture of additional binding energy.
To illuminate the binding mode of compounds 2 and 3 with
BcGH76, we soaked these inhibitors into crystals of the enzyme
and solved their X-ray structures to resolutions of 1.69 and
1.46 Å, respectively (Fig. 2a, b and Table S1, ESI†). ManSIFG 2
bound in the 2/1 subsites and (ManS)2IFG 3 bound in the
3/2/1 subsites. As the interactions of the two inhibitors in
the 2/1 subsites are essentially identical, the subsequent
discussion will mainly focus on the higher aﬃnity inhibitor
(ManS)2IFG 3. Superficially, the three residues of this inhibitor
occupy similar positions to the equivalent residues in a previously
reported Michaelis complex in which a-mannopentaose was
bound across the 4 to +1 subsites, and a complex with ManIFG
1, in which this inhibitor bound in the 2/1 subsites.9 In the
BcGH76–ManIFG complex the isofagomine moiety was in a B2,5
conformation and engaged in a close contact (2.8 Å) with the
enzymatic nucleophile, Asp124, an interaction that is typical for
IFG-type inhibitors of retaining glycosidases (see summary in
Table S2, ESI†). Interestingly, a longer (and presumably weaker)
interaction of ManIFG with the acid/base Asp125 was also evident
(N  O = 3.0 Å). Close inspection of the complexes with com-
pounds 2 and 3 reveals that while the non-reducing end residues
are positioned in the 3 and 2 subsites in essentially identical
fashions as for the previously reported complexes with O-linked
substrates and inhibitors, the IFG head-groups are positioned
atypically, such that the nitrogen is engaged in a close contact
with the acid/base Asp125 (N  O distance, 2 : 2.7 Å, 3 : 2.6 Å) and
an N–H p interaction with Phe122 (for a summary of published
complexes with IFG-type inhibitors see ESI,† Table S2). In contrast
with the complex of ManIFG with BcGH76, which was observed in
a B2,5 conformation,
9 in these complexes the isofagomine moiety
is found in an undistorted 4C1 conformation.
22 We speculate that
this close interaction involves a salt bridge with the protonated
nitrogen of the inhibitor and the deprotonated Asp125 residue.
Overlay of the binding mode of 1 and 2 or 3, reveals that the
binding of the latter pair of inhibitors results in a rotation of the
IFG head group about the S–C4(IFG) bond (Fig. 2c).
Scheme 1 Synthesis of S-linked isofagomine inhibitors ManSIFG (2) and
(Man)2SIFG (3). Tol = 4-methylbenzoyl.
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While the binding of compounds 2 and 3 are atypical for
IFG-based inhibitors in that they do not engage with the
enzymatic nucleophile, the coincidentally similar aﬃnities of
compounds 1 and 2 most likely arise from the inhibitors
achieving equivalent ionic interactions with the enzymatic
acid/base. The present complexes merit comparison with the
complex of a cellobiose-like isofagomine with the inverting GH
family 9 Cel9A from Alicyclobacillus acidocaldarius.11 In that case
two molecules of the cellobiose-like isofagomine were observed
in the complex, with one bound in the typical 2/1 mode, with
the isofagomine nitrogen interacting with the general acid
residue (Asp146). Remarkably, a second molecule of cello-IFG
was bound in a reversedmode in the +2/+1 subsites, with the IFG
moiety bound in the +1 subsite and the nitrogen interacting with
the general base residue (Glu515).
We sought to understand the underlying reasons for the
atypical binding modes observed for inhibitors 2 and 3 using a
computational approach (molecular dynamics).24 Initially, we
explored the protonation state of the catalytic residues in the
BcGH76–ManIFG and BcGH76–ManSIFG complexes. In both
cases, the IFG moiety was assumed to be protonated on the basis
of its high basicity; this has been directly observed experimentally
in crystallographic studies of cellulase Cel5A.25 Only models in
which the ammonium-interacting carboxyl residue (the nucleo-
phile and the acid/base, respectively) was deprotonated (Fig. 3 and
see also ESI,† Fig. S2, S3) could faithfully recapitulate the X-ray
structures (for an overlay, see ESI,† Fig. S4). Therefore, there is
change of protonation state of the catalytic residues upon binding
of ManSIFG in comparison to ManIFG, concurrent with the
change of binding pose.
Additional simulations in which O was replaced by S (and
vice versa) in the corresponding complexes did not result in reversion
of the binding mode of the ligand (i.e. replacement of O by S in
BcGH76–ManIFG did not make the in silico complex evolve towards
the ‘‘observed’’ BcGH76–ManSIFG, and vice versa). This suggests that
the individual binding poses are stable states separated by a sizable
energy barrier and that the two ligands achieve their respective
modes directly during binding and not by inter-conversion between
binding modes once bound. Further, for the BcGH76–ManIFG
complex (Fig. 3a), the nucleophile–ammonium interaction appears
to dominate binding, while the protonation state of the acid/base
(D125) is less important, most likely because of the lack of an
aglycon. By contrast, for the BcGH76–ManSIFG complex (Fig. 3b), in
which the inhibitor ammonium group interacts with the deproto-
nated acid/base residue (see ESI,† Fig. S5), the nucleophile (D124)
must be protonated. In this case, both experimentally and through-
out theMD simulation, a watermolecule is observed to interact with
the protonated nucleophile that approximately occupies the position
of the 3-OH residue in the ManIFG complex, thereby recapitulating
this interaction.
S-Linked oligosaccharides are useful substrate mimics that
have been used to illuminate the active site details of a range of
Fig. 2 Complexes of BcGH76 with (a) ManSIFG 2 (PDB: 5N0F) and (b)
(ManS)2IFG 3 (PDB: 5M77) (c) overlay of complexes of BcGH76 with
(ManS)2IFG and ManIFG 1 (PDB: 4D4D).
9 Electron density meshes are
sA-weighted 2F0  Fc contoured at 1s (0.32 electrons per Å
3), assembled
using CCP4mg.23
Fig. 3 Calculated complexes of BcGH76 with (a) ManIFG 1 and (b)
ManSIFG 2.
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glycosidases;26 however, their use has not been without controversy.
For example, recent work on a GH family 125 a-mannosidase from
Clostridium perfringens (CpGH125) revealed significant diﬀerences in
the preferred conformations of O- and S-linked 1,6-a-mannobioses
bound in the 1/+1 subsites.27 Thus, while the S-linked 1,6-a-
thiomannobiose was observed to bind in a 4C1 conformation,
QM/MM MD predicted the 1,6-a-mannobiose to bind in an OS2
conformation to wildtype, and X-ray crystallography revealed it
to bind in the same conformation to a disabled enzyme mutated
at the catalytic acid residue. Another notable example is that of
an active-site spanning Michaelis complex of a thiocellopentao-
side bound to a Fusarium oxysporum cellulase, for which electron
density for only three sugar residues could be observed in the
X-ray structure.28 In both cases these anomalous observations
likely result from the longer length of a C–S bond (1.89 vs. 1.48 Å
for C–O) in a thioglycoside.27 These two prior studies, and the
present work bring to attention the subtle yet significant limita-
tions that sulfur-for-oxygen substitution within glycosides can
have upon biological recognition by glycosidases.
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